Mesa Laboratories, Inc.MLABNASDAQ
Loading
EBITDA Margin Over TimeStrong
Percentile Rank40
3Y CAGR+1.5%
5Y CAGR-3.0%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

3Y CAGR
+1.5%/yr
vs -0.6%/yr prior
5Y CAGR
-3.0%/yr
Recent acceleration
Acceleration
+2.1pp
Accelerating
Percentile
P40
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
2 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM17.91%+1.9%
202517.57%+115.9%
2024-110.26%-743.9%
202317.12%-3.0%
202217.65%-15.6%
202120.90%+10.0%
202019.00%+8.3%
201917.54%+72.7%
201810.16%-62.0%
201726.74%-